Valuation: China Isotope & Radiation Corporation

Market Cap 3.22B 3.77B 482M 430M 397M 360M 676M 45.62B 686M 4.78B 1.88B 23.9B 1.81B 1.77B 75.72B P/E 2024
8.03x
P/E 2025 17.7x
Enterprise Value 3.33B 3.91B 499M 446M 411M 374M 701M 47.31B 712M 4.95B 1.95B 24.79B 1.87B 1.83B 78.52B EV / Sales 2024
0.42x
EV / Sales 2025 0.82x
Free-Float
91.44%
Yield 2024
3.74%
Yield 2025 1.69%
Oct. 22 China Isotope & Radiation to Issue New Shares in Subsidiary; Shares Fall 4% MT
Oct. 21 China Isotope & Radiation Declares Interim Dividend MT
Oct. 21 China Isotope & Radiation Corporation Approves Appointment of Li Penghui as Executive Director, Effective 21 October 2026 CI
Oct. 21 China Isotope & Radiation Corporation Approves Interim Dividend for the Six Months Ended 30 June 2026, Payable Before 18 December 2026 CI
Oct. 11 CIRC Unit's H. Pylori Breath Test Kit Wins China Drug Registration Approval MT
Sep. 22 China Isotope & Radiation Unit's Lu-177 API Filing Clears US FDA Review MT
Aug. 28 China Isotope & Radiation Corporation Reports Earnings Results for the Half Year Ended June 30, 2026 CI
Aug. 28 China Isotope & Radiation Corporation Proposes Interim Dividend for the Six Months Ended 30 June 2026, Payable on 18 December 2026 CI
Aug. 28 China Isotope & Radiation Corporation Announces Resignation of Zhang Junqi as an Executive Director, A Member of the Strategy Committee of the Board and A Member of the Science and Technology Innovation Committee of the Board, Effective August 28, 2026 CI
Aug. 28 China Isotope & Radiation Corporation Announces CEO Changes, Effective August 28, 2026 CI
Jul. 05 China Isotope to Form JV With Associate MT
Jul. 03 China Isotope & Radiation Corporation and CNNC Yuanke Enter into Shareholders? Agreement to Establish Joint Venture Company CNNC Fuyuan CI
Jun. 18 China Isotope & Radiation Corporation Approves Final Dividend for the Year Ended 31 December 2025, Payable on Before 17 August 2026 CI
1 day+1.08%
1 week-3.12%
Current month-10.12%
1 month-15.64%
3 months-31.14%
6 months-36.71%
Current year-41.53%
1 week 11
Extreme 11
12.44
1 month 11
Extreme 11
14.43
Current year 11
Extreme 11
24.28
1 year 11
Extreme 11
25
3 years 9.03
Extreme 9.03
25
5 years 9.03
Extreme 9.03
26.5
10 years 9.03
Extreme 9.03
35.4
Manager TitleAgeSince
Chief Executive Officer 54 2026-08-27
Corporate Secretary - 2024-08-29
Corporate Secretary - 2024-08-29
Director TitleAgeSince
Director/Board Member 57 2017-02-21
Director/Board Member 54 2019-06-27
Director/Board Member 54 2019-12-29
Change 5-day change 1-year change 3-year change Capi.($)
+2.71%-3.12%-31.34%-1.42% 482M
+1.99%-2.07%-19.88%+5.92% 177B
+3.83%+1.19%+0.72%+32.86% 118B
+3.19%+4.72%-20.93%+15.58% 118B
+0.59%+15.41%-42.90%+7.67% 91.21B
-0.57%-0.86%+2.32%+79.33% 64.59B
-1.06%+1.75%+13.50%+80.00% 56.13B
+3.13%+3.44%+6.54%-22.51% 54.59B
+2.40%+3.58%-10.57%+32.73% 43.6B
-0.10%+5.26%-5.45%-11.14% 33.95B
Average +1.45%+3.64%-10.80%+21.90% 75.8B
Weighted average by Cap. +1.86%+3.77%-12.16%+22.30%

Financials

2024 2025
Net sales 7.57B 8.89B 1.13B 1.01B 934M 849M 1.59B 107B 1.62B 11.26B 4.43B 56.31B 4.26B 4.17B 178B 7.19B 8.44B 1.08B 961M 887M 805M 1.51B 102B 1.53B 10.68B 4.21B 53.43B 4.04B 3.95B 169B
Net income 407M 477M 60.91M 54.37M 50.16M 45.57M 85.49M 5.77B 86.8M 604M 238M 3.02B 229M 224M 9.58B 327M 384M 49.05M 43.78M 40.39M 36.69M 68.84M 4.65B 69.89M 487M 192M 2.43B 184M 180M 7.71B
Net Debt -109M -128M -16.32M -14.56M -13.44M -12.21M -22.9M -1.55B -23.25M -162M -63.76M -810M -61.25M -59.94M -2.57B 119M 139M 17.8M 15.89M 14.66M 13.32M 24.98M 1.69B 25.37M 177M 69.56M 883M 66.82M 65.39M 2.8B
Projected Income Statement - Annual - China Isotope & Radiation Corporation
Logo China Isotope & Radiation Corporation
China Isotope & Radiation Corp is a China-based company mainly engaged in the research, development, manufacturing and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products. The Company operates five business segments. Pharmaceuticals segment is engaged in providing imaging diagnostic and therapeutic radiopharmaceuticals, urea breath test (UBT) kits and analyzers and in vitro diagnostic reagents and kits. Radioactive Source Products segment is engaged in providing various medical and industrial radioactive sources products as well as provision of related technical services. Irradiation segment is engaged in providing sterilization services. Radiation Therapy Equipment and Related Services segment is engaged in manufacturing Radiation therapy equipment. Other Businesses segment is engaged in providing trade services in relation to imported radioactive source, medical nuclides, imported radiopharmaceuticals, and other products.
Employees
3,655
Date Price Change Volume
26-10-23 HK$12.00 +2.71% 57,200
26-10-22 HK$11.80 -2.96% 365,000
26-10-21 HK$12.16 +1.50% 50,400
26-10-20 HK$11.98 -1.72% 126,600
26-10-16 HK$12.19 +1.84% 114,200

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - China Isotope & Radiation Corporation
  1. Stock Market
  2. Stocks
  3. 1763 Stock